Old Web
English
Sign In
Acemap
>
authorDetail
>
Ranjana Tavorath
Ranjana Tavorath
Medicine
Chemotherapy
PI3K/AKT/mTOR pathway
Breast cancer
Combined Modality Therapy
4
Papers
300
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
PI3K inhibitors as new cancer therapeutics: implications for clinical trial design
2016
OncoTargets and Therapy
Cristian Massacesi
Emmanuelle di Tomaso
Patrick Urban
Caroline Germa
Cornelia Quadt
Lucia Trandafir
Paola Aimone
Nathalie Fretault
Bharani Dharan
Ranjana Tavorath
Samit Hirawat
Show All
Source
Cite
Save
Citations (169)
Overcoming Phosphatidylinositol 3-Kinase (PI3K) Activation in Breast Cancer: Emerging PI3K Inhibitors
2015
Cristian Massacesi
Emmanuelle di Tomaso
Patrick Urban
Caroline Germa
Nathalie Fretault
Bharani Bharani-Dharan
Ranjana Tavorath
Cornelia Quadt
Christina Coughlin
Samit Hirawat
Show All
Source
Cite
Save
Citations (4)
Drug Treatment of Chemotherapy-Induced Delayed Emesis
1996
Drugs
Ranjana Tavorath
Paul J. Hesketh
Show All
Source
Cite
Save
Citations (122)
Chemotherapy for recurrent disease and combined modality therapies for head and neck cancer.
1995
Current Opinion in Oncology
Ranjana Tavorath
David G. Pfister
Show All
Source
Cite
Save
Citations (5)
1